Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1530
Embargo will expire:
15-Nov-2018 12:00 AM EST
Released to reporters:
12-Nov-2018 12:00 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 15-Nov-2018 12:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
15-Nov-2018 12:00 AM EST
Released to reporters:
12-Nov-2018 12:00 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 15-Nov-2018 12:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
15-Nov-2018 12:00 AM EST
Released to reporters:
12-Nov-2018 12:00 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 15-Nov-2018 12:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
15-Nov-2018 12:00 AM EST
Released to reporters:
12-Nov-2018 12:00 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 15-Nov-2018 12:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Embargo will expire:
15-Nov-2018 12:00 AM EST
Released to reporters:
12-Nov-2018 12:00 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 15-Nov-2018 12:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

OpioidRescueKitNR.jpg

Article ID: 703571

The Medical Minute: Naloxone rescue kits now being prescribed alongside high-dose prescriptions

Penn State Health

Doctors now regularly prescribe drugs that reverse the effects of opioids in tandem with high-dose prescriptions of the painkillers.

Released:
7-Nov-2018 3:05 PM EST
ELUVIA_Illustration_Scurve_WHITE_rgb.jpg

Article ID: 703371

Mount Sinai Is First to Use FDA-Approved Drug-Eluting Stent That Treats Peripheral Artery Disease

Mount Sinai Health System

Vascular specialists at the Icahn School of Medicine at Mount Sinai are the first in the United States to use the Eluvia™, a drug-eluting vascular stent system for clinical treatment of peripheral artery disease (PAD), a circulatory condition that causes a narrowing of the blood vessels and a reduction of blood flow to the limbs.

Released:
5-Nov-2018 11:00 AM EST

Article ID: 703355

Bertarelli Foundation, Harvard Medical School Announce Collaborative Research Awards to Tackle Sensory Disorders

Harvard Medical School

The grants are designed to foster cross-disciplinary cooperation among leading basic, translational and clinical neuroscientists in an effort to propel discoveries from laboratory to clinic.

Released:
5-Nov-2018 9:45 AM EST

Article ID: 703313

Óleo de gerânio rosa pode aliviar sintomas nasais dolorosos relacionados ao tratamento de câncer

Mayo Clinic

O óleo de gerânio rosa pode ajudar a aliviar os sintomas da vestibulite nasal, uma condição nasal comum e dolorosa relacionada ao tratamento medicamentoso de câncer, de acordo com o resultado de um breve estudo observacional publicado on-line no BMJ Supportive & Palliative Care.

Released:
2-Nov-2018 2:05 PM EDT

Article ID: 703314

زيت زهرة الغرنوقي قد يخفف من الأعراض الشائعة لآلام الأنف والمرتبطة بعلاج السرطان

Mayo Clinic

روتشستر، مينيسوتا. — قد يساعد زيت زهرة الغرنوقي في التخفيف من أعراض التهاب دهليز الأنف الذي يعد حالة أنفية شائعة مؤلمة ترتبط بالعلاج الدوائي لمرض السرطان، وذلك وفقًا لنتائج دراسة وصفية صغيرة نُشرت على الموقع الإلكتروني للمجلة الطبية البريطانية للرعاية الداعمة والتلطيفية (BMJ Supportive and Palliative Care).

Released:
2-Nov-2018 2:05 PM EDT

Showing results

110 of 1530

Chat now!